For those with kidney failure, the wait for a new kidney can take years. There just are not enough organs from deceased ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...

Patients with a nonrejection-related diagnosis according to the 2019 Banff classification who were reclassified as MVI, ...

The former prom dates hadn’t been in touch in decades, but Elena Hershey decided to donate her kidney when she heard about ...

In Part A of the trial, subjects will be given nine intravenous infusions of either the drug or placebo over a six-month period.

Biogen BIIB announced that dosing has begun in a phase III study evaluating its key pipeline candidate, felzartamab, in adult kidney transplant recipients diagnosed with late antibody-mediated ...

Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...

NEW YORK, March 5, 2025 /PRNewswire/ -- Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived ...